{
  "EXAMPLE_PEPTIDE": {
    "General Information": {
      "Fragment": "EXAMPLE_PEPTIDE",
      "Gene Names": "GENE1; GENE2; GENE3",
      "Entries": "P12345; Q67890; A1B2C3",
      "Cleavage Sites": "15; 22; 35",
      "Gene": "EXAMPLE_GENE",
      "Gene description": "Example gene for peptide analysis application",
      "Molecular function": "Enzyme; Binding protein; Signaling",
      "Biological process": "Cell cycle; DNA repair; Signal transduction",
      "Disease involvement": "Cancer; Genetic disorder",
      "Evidence": "Evidence at protein level",
      "RNA tissue specificity": "Tissue enhanced",
      "RNA tissue distribution": "Detected in many",
      "Subcellular location": "Nucleus; Cytoplasm",
      "Subcellular main location": "Nucleus",
      "TAU score - Tissue": "0.65",
      "Signal Peptide Sequence": "MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETAQMQTLQALMLLQVQEELLSSQVTQELRALMDETAQMQTLQALMLLQ"
    },
    "Tissue Expression": {
      "Tissue RNA - adipose tissue [nTPM]": 12.5,
      "Tissue RNA - adrenal gland [nTPM]": 8.2,
      "Tissue RNA - amygdala [nTPM]": 15.7,
      "Tissue RNA - appendix [nTPM]": 6.3,
      "Tissue RNA - basal ganglia [nTPM]": 22.1,
      "Tissue RNA - bone marrow [nTPM]": 3.8,
      "Tissue RNA - breast [nTPM]": 18.9,
      "Tissue RNA - cerebellum [nTPM]": 45.2,
      "Tissue RNA - cerebral cortex [nTPM]": 67.4,
      "Tissue RNA - cervix [nTPM]": 11.6,
      "Tissue RNA - colon [nTPM]": 29.3,
      "Tissue RNA - duodenum [nTPM]": 156.8,
      "Tissue RNA - endometrium [nTPM]": 14.2,
      "Tissue RNA - esophagus [nTPM]": 9.7,
      "Tissue RNA - heart muscle [nTPM]": 25.4,
      "Tissue RNA - kidney [nTPM]": 38.1,
      "Tissue RNA - liver [nTPM]": 87.6,
      "Tissue RNA - lung [nTPM]": 42.3,
      "Tissue RNA - lymph node [nTPM]": 16.8,
      "Tissue RNA - ovary [nTPM]": 13.5,
      "Tissue RNA - pancreas [nTPM]": 31.7,
      "Tissue RNA - prostate [nTPM]": 19.4,
      "Tissue RNA - skeletal muscle [nTPM]": 21.8,
      "Tissue RNA - skin [nTPM]": 35.6,
      "Tissue RNA - small intestine [nTPM]": 89.2,
      "Tissue RNA - spleen [nTPM]": 28.7,
      "Tissue RNA - stomach [nTPM]": 52.3,
      "Tissue RNA - testis [nTPM]": 17.9,
      "Tissue RNA - thyroid gland [nTPM]": 24.1,
      "Tissue RNA - tonsil [nTPM]": 33.4,
      "Tissue RNA - urinary bladder [nTPM]": 12.8
    },
    "Cancer Expression": {
      "Cancer - breast cancer [nTPM]": 45.2,
      "Cancer - lung cancer [nTPM]": 32.8,
      "Cancer - colorectal cancer [nTPM]": 28.7,
      "Cancer - prostate cancer [nTPM]": 38.1,
      "Cancer - liver cancer [nTPM]": 51.6,
      "Cancer - stomach cancer [nTPM]": 29.4,
      "Cancer - kidney cancer [nTPM]": 22.3,
      "Cancer - bladder cancer [nTPM]": 18.9,
      "Cancer - ovarian cancer [nTPM]": 26.7,
      "Cancer - pancreatic cancer [nTPM]": 35.8,
      "Cancer - brain cancer [nTPM]": 41.2,
      "Cancer - leukemia [nTPM]": 15.4,
      "Cancer - lymphoma [nTPM]": 19.8,
      "Cancer - melanoma [nTPM]": 33.6,
      "Cancer - cervical cancer [nTPM]": 24.3
    },
    "HLA Binding": {
      "HLA-A*01:01": 0.12,
      "HLA-A*02:01": 0.89,
      "HLA-A*03:01": 0.45,
      "HLA-A*24:02": 0.67,
      "HLA-A*26:01": 0.23,
      "HLA-B*07:02": 0.78,
      "HLA-B*08:01": 0.34,
      "HLA-B*15:01": 0.56,
      "HLA-B*27:05": 0.91,
      "HLA-B*35:01": 0.42,
      "HLA-B*40:01": 0.68,
      "HLA-B*44:02": 0.85,
      "HLA-C*03:03": 0.29,
      "HLA-C*04:01": 0.73,
      "HLA-C*06:02": 0.51,
      "HLA-C*07:01": 0.39,
      "HLA-C*12:03": 0.64,
      "HLA-C*15:02": 0.87
    },
    "TAP Binding": {
      "TAP Score": 0.75,
      "TAP Prediction": "Good binder",
      "TAP Binding Affinity": "High"
    },
    "Immunogenicity": {
      "Immunogenicity Score": 0.82,
      "T-cell Response": "Strong",
      "Antigenicity": "High"
    }
  },
  "ANOTHER_PEPTIDE": {
    "General Information": {
      "Fragment": "ANOTHER_PEPTIDE",
      "Gene Names": "GENE4; GENE5",
      "Entries": "P54321; Q09876",
      "Cleavage Sites": "8; 16",
      "Gene": "ANOTHER_GENE",
      "Gene description": "Another example gene for demonstration",
      "Molecular function": "Transcription factor; DNA binding",
      "Biological process": "Gene expression; Development",
      "Disease involvement": "Autoimmune disease",
      "Evidence": "Evidence at transcript level",
      "RNA tissue specificity": "Low tissue specificity",
      "RNA tissue distribution": "Detected in all",
      "Subcellular location": "Nucleus",
      "Subcellular main location": "Nucleus",
      "TAU score - Tissue": "0.25",
      "Signal Peptide Sequence": "MKLLILTCLVAVALARPKHPIKHQGLPQEVLNENLLRFFDSVCGGASQWKEAAQLLWKQEGLHREFFPEDVAEAFFDEFIQEEVAAGASQWKEAAQLLWKQEG"
    },
    "Tissue Expression": {
      "Tissue RNA - adipose tissue [nTPM]": 89.3,
      "Tissue RNA - adrenal gland [nTPM]": 95.7,
      "Tissue RNA - brain [nTPM]": 112.4,
      "Tissue RNA - heart muscle [nTPM]": 78.2,
      "Tissue RNA - kidney [nTPM]": 101.8,
      "Tissue RNA - liver [nTPM]": 134.6,
      "Tissue RNA - lung [nTPM]": 87.9,
      "Tissue RNA - skeletal muscle [nTPM]": 92.3,
      "Tissue RNA - skin [nTPM]": 76.8
    },
    "Cancer Expression": {
      "Cancer - breast cancer [nTPM]": 123.4,
      "Cancer - lung cancer [nTPM]": 98.7,
      "Cancer - colorectal cancer [nTPM]": 156.2,
      "Cancer - liver cancer [nTPM]": 187.9,
      "Cancer - brain cancer [nTPM]": 145.3
    },
    "HLA Binding": {
      "HLA-A*01:01": 0.91,
      "HLA-A*02:01": 0.23,
      "HLA-A*03:01": 0.67,
      "HLA-B*07:02": 0.45,
      "HLA-B*08:01": 0.89,
      "HLA-C*03:03": 0.78,
      "HLA-C*04:01": 0.34
    }
  }
}